Frank Baehner

2.3k total citations
27 papers, 1.6k citations indexed

About

Frank Baehner is a scholar working on Infectious Diseases, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Frank Baehner has authored 27 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 11 papers in Epidemiology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Frank Baehner's work include Viral gastroenteritis research and epidemiology (13 papers), Viral Infections and Immunology Research (9 papers) and Lysosomal Storage Disorders Research (8 papers). Frank Baehner is often cited by papers focused on Viral gastroenteritis research and epidemiology (13 papers), Viral Infections and Immunology Research (9 papers) and Lysosomal Storage Disorders Research (8 papers). Frank Baehner collaborates with scholars based in United States, Switzerland and Germany. Frank Baehner's co-authors include Christoph Kampmann, Michael Beck, Catharina Whybra, Elke Miebach, Christiane M. Wiethoff, Frank Krummenauer, Andreas Gal, Astrid Borkowski, Markus Ries and Alfried Kohlschütter and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and Journal of the American Society of Nephrology.

In The Last Decade

Frank Baehner

26 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Baehner United States 18 981 790 419 304 242 27 1.6k
Stanley J. Naides United States 28 89 0.1× 236 0.3× 1.4k 3.4× 203 0.7× 64 0.3× 74 2.2k
Caroline M. Percopo United States 20 415 0.4× 358 0.5× 205 0.5× 177 0.6× 12 0.0× 58 1.5k
Laurent Bélec France 15 81 0.1× 366 0.5× 472 1.1× 126 0.4× 91 0.4× 38 1.2k
Rosa Vitale Italy 11 76 0.1× 287 0.4× 231 0.6× 34 0.1× 171 0.7× 18 1.1k
Pam Drysdale United Kingdom 9 124 0.1× 601 0.8× 579 1.4× 25 0.1× 22 0.1× 10 1.4k
Matthew E. Wikström Australia 23 481 0.5× 460 0.6× 122 0.3× 31 0.1× 14 0.1× 38 2.3k
Mary Beth Fasano United States 20 301 0.3× 248 0.3× 88 0.2× 53 0.2× 46 0.2× 40 1.3k
Mary Renshaw United States 13 56 0.1× 629 0.8× 182 0.4× 37 0.1× 49 0.2× 17 1.3k
Antonio Volpi Italy 23 144 0.1× 979 1.2× 165 0.4× 84 0.3× 122 0.5× 79 1.6k
Ronei Luciano Mamoni Brazil 20 78 0.1× 772 1.0× 459 1.1× 62 0.2× 59 0.2× 51 1.5k

Countries citing papers authored by Frank Baehner

Since Specialization
Citations

This map shows the geographic impact of Frank Baehner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Baehner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Baehner more than expected).

Fields of papers citing papers by Frank Baehner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Baehner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Baehner. The network helps show where Frank Baehner may publish in the future.

Co-authorship network of co-authors of Frank Baehner

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Baehner. A scholar is included among the top collaborators of Frank Baehner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Baehner. Frank Baehner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sáez‐Llorens, Xavier, Rodrigo DeAntonio, Eduardo López-Medina, et al.. (2025). Safety and immunogenicity of a bivalent norovirus vaccine candidate in infants from 6 weeks to 5 months of age: A phase 2, randomized, double-blind trial. Human Vaccines & Immunotherapeutics. 21(1). 2450878–2450878. 2 indexed citations
2.
3.
Burden, A. David, Robert Bissonnette, Alexander A. Navarini, et al.. (2023). Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study. Dermatology and Therapy. 13(10). 2279–2297. 13 indexed citations
4.
Pinter, Andreas, Satomi Kobayashi, Stacie Bell, et al.. (2023). Understanding potential participation barriers to improve trial design and outcomes: clinical trial simulation in palmoplantar pustulosis as a case study. BMJ Open. 13(4). e064159–e064159.
5.
Vesikari, Timo, Xavier Sáez‐Llorens, Vesna Blazevic, et al.. (2022). Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: A phase 2 randomized, double-blind study. Vaccine. 40(26). 3588–3596. 18 indexed citations
6.
Treanor, John, et al.. (2020). A phase 2 study of the bivalent VLP norovirus vaccine candidate in older adults; impact of MPL adjuvant or a second dose. Vaccine. 38(36). 5842–5850. 26 indexed citations
7.
Atmar, Robert L., Frank Baehner, Jakob P. Cramer, et al.. (2019). Persistence of Antibodies to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: 1-Year Follow-up With Memory Probe Vaccination. The Journal of Infectious Diseases. 220(4). 603–614. 22 indexed citations
8.
Lindesmith, Lisa C., Michael L. Mallory, Taylor Jones, et al.. (2017). Impact of Pre-Exposure History and Host Genetics on Antibody Avidity Following Norovirus Vaccination. The Journal of Infectious Diseases. 215(6). 984–991. 18 indexed citations
9.
Leroux‐Roels, Geert, Jakob P. Cramer, Paul M. Mendelman, et al.. (2017). Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial. The Journal of Infectious Diseases. 217(4). 597–607. 57 indexed citations
10.
Ramani, Sasirekha, Frederick H. Neill, Jennifer Ferreira, et al.. (2017). B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine. Clinical and Vaccine Immunology. 24(5). 17 indexed citations
11.
Atmar, Robert L., Frank Baehner, Jakob P. Cramer, et al.. (2016). Rapid Responses to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: A Randomized Controlled Trial. The Journal of Infectious Diseases. 214(6). 845–853. 50 indexed citations
12.
Baehner, Frank, H. Bogaerts, & Robert R. Goodwin. (2016). Vaccines against norovirus: state of the art trials in children and adults. Clinical Microbiology and Infection. 22. S136–S139. 17 indexed citations
13.
Costantini, Marco, et al.. (2015). SAFETY OF A CRM197-CONJUGATED HAEMOPHILUS INFLUENZAE TYPE B VACCINE IN KOREAN CHILDREN.. PubMed. 46(4). 743–52. 1 indexed citations
14.
Vesikari, Timo, Markus Knuf, Peter Wutzler, et al.. (2011). Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children. New England Journal of Medicine. 365(15). 1406–1416. 230 indexed citations
15.
Kampmann, Christoph, Aleš Linhart, Frank Baehner, et al.. (2008). Onset and progression of the Anderson–Fabry disease related cardiomyopathy. International Journal of Cardiology. 130(3). 367–373. 126 indexed citations
16.
Kampmann, Christoph, Christiane M. Wiethoff, Catharina Whybra, et al.. (2008). Cardiac manifestations of Anderson‐Fabry disease in children and adolescents. Acta Paediatrica. 97(4). 463–469. 69 indexed citations
17.
Whybra, Catharina, Andreas Schwarting, Jörg Kriegsmann, et al.. (2006). IgA nephropathy in two adolescent sisters heterozygous for Fabry disease. Pediatric Nephrology. 21(9). 1251–1256. 22 indexed citations
18.
Whybra, Catharina, Christoph Kampmann, Frank Krummenauer, et al.. (2004). The Mainz Severity Score Index: a new instrument for quantifying the Anderson–Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clinical Genetics. 65(4). 299–307. 220 indexed citations
19.
Kampmann, Christoph, Frank Baehner, Catharina Whybra, et al.. (2002). Cardiac manifestations of Anderson–Fabry disease in heterozygous females. Journal of the American College of Cardiology. 40(9). 1668–1674. 150 indexed citations
20.
Kampmann, Christoph, Frank Baehner, Markus Ries, & Michael Beck. (2002). Cardiac Involvement in Anderson-Fabry Disease. Journal of the American Society of Nephrology. 13(suppl_2). S147–S149. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanley J. Naides Breakdown of academic impact, for papers by Caroline M. Percopo Breakdown of academic impact, for papers by Laurent Bélec Breakdown of academic impact, for papers by Rosa Vitale Breakdown of academic impact, for papers by Pam Drysdale Breakdown of academic impact, for papers by Matthew E. Wikström Breakdown of academic impact, for papers by Mary Beth Fasano Breakdown of academic impact, for papers by Mary Renshaw Breakdown of academic impact, for papers by Antonio Volpi Breakdown of academic impact, for papers by Ronei Luciano Mamoni
Rankless by CCL
2026